ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,540Medicare Part D Prescriptions Filled, Including Refills

Rank: 183 out of 1111

$594K Total Retail Price of All Prescriptions

Rank: 153 out of 1111

271 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

24% of this provider’s 271 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 8,231 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 345 309 1 2
FUROSEMIDE 332 308 2 6
LEVOTHYROXINE SODIUM 324 292 3 3
OMEPRAZOLE 277 230 4 4
GABAPENTIN 247 184 5 10
HYDROCODONE-ACETAMINOPHEN 244 152 S3 6 1
SIMVASTATIN 244 217 6 5
AMLODIPINE BESYLATE 244 228 6 7
POTASSIUM CHLORIDE 239 222 9 9
METOPROLOL TARTRATE 229 212 10 12
POLYETHYLENE GLYCOL 3350 193 177 11 45
MIRTAZAPINE 192 168 12 52
DONEPEZIL HCL 176 168 13 25
NAMENDA 155 143 14 31
TRAMADOL HCL 144 118 15 13
LANTUS 136 117 16 46
METFORMIN HCL 128 121 17 8
CITALOPRAM HBR 128 112 17 14
CLOPIDOGREL 119 113 19 30
FAMOTIDINE 116 100 20 77
CARVEDILOL 111 95 21 21
SERTRALINE HCL 106 88 22 24
KLOR-CON M20 105 98 23 79
CYMBALTA 102 99 24 40
ESCITALOPRAM OXALATE 95 86 25 78
OXYBUTYNIN CHLORIDE ER 91 91 26 114
ALBUTEROL SULFATE 90 89 27 136
ADVAIR DISKUS 88 77 28 43
PANTOPRAZOLE SODIUM 88 74 28 50
HYDROCHLOROTHIAZIDE 87 80 30 11
MELOXICAM 85 81 31 18
ATORVASTATIN CALCIUM 85 66 31 15
NOVOLOG 79 59 33 104
IBUPROFEN 76 69 34 66
TRAVATAN Z 75 75 35 183
DIGOXIN 74 74 36 47
PLAVIX 74 66 36 49
RISPERIDONE 73 73 38 60
WARFARIN SODIUM 61 61 39 19
HUMALOG 60 54 40 202
NITROGLYCERIN PATCH 60 60 40 245
LEVOFLOXACIN 53 42 42 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.